Pr ecis: The use of tumor-homing macrophages to deliver an oncolytic virus may leverage favorable responses to chemotherapy in cancer, potentially identifying a niche to apply a technology that has yet to produce much clinical impact. Pr ecis: This study reports the development of a computational tool that can reliably predict colon cancer patient responses to chemotherapy and might also be useful for prognosis and patient stratification in the future.
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Systems Analysis of BCL2 Protein Family Interactions Establishes a Model to Predict Responses to Chemotherapy
Pr ecis: A G protein-coupled receptor implicated in airway inflammation responses supports immune surveillance by restraining macrophages to the tumor cell-killing M1 phenotype.
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CD40-Mediated Activation of Chronic Lymphocytic Leukemia Cells Promotes Their CD44-Dependent Adhesion to Hyaluronan and Restricts CCL21-Induced Motility
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Pr ecis: The evolution of a specific adhesion event in the lymph node microenvironment where a particular leukemia arises is found to be a critical event in determining the outgrowth of these cancers.
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CXCR2 Expression in Tumor Cells is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
Pr ecis: A logical strategy to treat smokingassociated lung cancers is suggested by the definition of a proinflammatory signaling axis that cooperates with Ras mutations commonly found in this disease. To request permission to re-use all or part of this article, contact the AACR Publications Department at
